⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Aging Omic Biomarkers and Clocks
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-15 — Circulating C-Terminal Agrin Fragment is Associated with Impaired Physical Performance in Aging and Chronic Disease: A Systematic Review and Meta-Analysis.: [human-observational] A systematic review and meta-analysis covering 21 studies and over 3,000 individuals adds circulating CAF22 as a candidate protein biomarker associated with slower gait speed and lower SPPB scores, rather than a calibrated aging clock or established surrogate endpoint for functional recovery or de-aging. [human-observational] (novelty: 3)
- 2026-11-12 — Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation: cross-connection with senescent-burden-biomarkers: [human-observational] Donor-liver transcriptomic profiling connects tissue-specific senescence signatures with omic aging biomarkers, without establishing a calibrated aging clock or validated predictor of graft outcomes. (novelty: 3)
- 2026-11-01 — Immunophenotypic Profiles of General Chinese Population during Natural Aging.: [human-observational] Observational CyTOF study of 605 healthy Chinese individuals profiled 50 immune-cell subsets, identified age-associated compositional shifts, and constructed an immune-age metric associated with lifestyle and physiological markers, without establishing prospective clinical-outcome prediction, test-retest reliability, batch robustness, independent validation, or intervention-induced de-aging. [human-observational] (novelty: 3)
- 2026-11-11 — Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.: [expert-opinion] Conceptual review proposes ‘Longevitomics’/‘Longevitome’ as a framework integrating multi-omics, environmental exposures, digital phenotyping, and AI-driven digital twins to model healthy-longevity trajectories, without supplying new outcome-prediction, test-retest reliability, or intervention-response validation. [expert-opinion] (novelty: 3)
- 2026-10-26 — Dissecting the shared genetic architecture of adipose tissue aging and aging-related lipid-metabolic dysfunction: a multivariate genomic analysis.: [human-observational] Human multivariate genomic analysis using Genomic SEM introduces mvAdiposeAge, a latent factor integrating fat distribution, ectopic lipid accumulation, and metabolic dysregulation, with prominent FTO-locus associations, brain/neurotrophin-pathway enrichment, and genetic associations with adiposity and lower cognitive performance—not a validated longitudinal aging clock or evidence of cognitive decline, intervention responsiveness, or de-aging. [human-observational] (novelty: 3)
- 2026-10-07 — Chronic inflammation and multiple dimensions of aging among women in the Philippines.: Adds a Philippines-based longitudinal data point to the DNAm-surrogate catalog: a methylation CRP surrogate predicted 7-year physical, cognitive, and cardiometabolic outcomes in Filipino women alongside plasma CRP — geographic extension of inflammation-anchored omic surrogates into a lower-middle-income, higher-infectious-burden population, observational. [human-observational] (novelty: 3)
- 2026-10-09 — Brain care score and retinal health: structural and metabolic insights from the UK Biobank.: UK Biobank Brain Care Score + OCT analysis adds lipid, unsaturated fatty acid, and branched-chain amino acid metabolites as candidate mediators of a brain-care lifestyle score’s association with retinal structural aging and an OCT age gap — extends the exposome→metabolome→retinal-aging pathway coverage, observational, cross-sectional. [human-observational] (novelty: 3)
- 2026-10-07 — Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.: Adds incident MASLD to the omic-biomarker outcome catalog via a UK Biobank prospective study where a five-protein plasma core (AXL, CCL19, CPM, REN, TNFRSF11B) partially mediated the link between four biological-age metrics and MASLD onset — extends outcome coverage into hepatic steatotic disease but partial mediation is not evidence that moving these proteins blocks MASLD. [human-observational] (novelty: 3)
- 2026-09-28 — Epigenetic age acceleration is associated with brain connectivity changes and the risk of major depression after trauma: Adds acute post-trauma (within 72h of ED presentation) as a time-sensitive measurement window to the omic-biomarker exposure catalog: GrimAge and DunedinPACE at that window predicted 6-month MDD incidence and fMRI connectivity changes, particularly in adults ≥35 — observational, extends outcome coverage to post-trauma psychiatric incidence and brain-network imaging. [human-observational] (novelty: 3)
- 2026-09-28 — Uncertainty redefines biological age: UK Biobank + external replication introduces biological age uncertainty (BAU) — the width of predicted-age distributions — as a dimension distinct from biological age gap that independently predicts mortality, multimorbidity, and healthspan loss, extending the omic-biomarker catalog from point-estimate age gaps to the dispersion of cross-molecule/cross-organ age signals as a separate outcome-linked readout. [human-observational] (novelty: 4)
- 2026-09-29 — Westlake Longevity Cohort: 2026 — Westlake Longevity Cohort (We-Longevity) announced as a prospective Chinese centenarian/nonagenarian multi-omics cohort aiming to characterize molecular trajectories of healthy longevity and link diet/lifestyle to omic profiles — extends the East-Asian reference layer (alongside the Hong Kong long-lived and 100-Year Human Aging studies), cohort-description only, no readout data. [expert-opinion] (novelty: 3)
- 2026-09-28 — A New Metric for Overall Senescent Cell Burden: Secondary news coverage frames the deep-learning SASP Score as a new blood-proteomic metric of overall senescent-cell burden — reiterates the already-logged primary finding without adding benchmark or outcome data, reinforcing the SASP-score layer as a candidate overlay on existing omic clocks. [expert-opinion] (novelty: 3)
- 2026-10-05 — An Aging Clock Based on Images of Hematopoietic Stem Cell Nuclei: 2026-10 — News-report of an HSC nuclear-image aging clock reiterates the image-based nuclear-architecture modality (overlapping with the ChromAgeNet preclinical entry) as an emerging non-sequencing addition to the aging-measurement surface; secondhand coverage, no new validation data. [expert-opinion] (novelty: 3)
- 2026-09-28 — Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images: Preclinical ChromAgeNet study (deep learning on 3D chromatin images of murine HSCs, AUROC ~0.77) adds an image-based nuclear-architecture modality to the aging-biomarker catalog, extending the measurement surface rather than validating any existing omic clock. [animal-model] (novelty: 3)
- 2026-10-01 — Organ-Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox.: 2026-09-24 — Perspective reframes earlier organ-specific proteomic-clock alcohol findings as a cautionary case where confounding and methodological heterogeneity produce apparent ‘healthy drinking’ signals, arguing organ-clock movement should not be interpreted as a protective biological effect — expert critique extending the exposure-catalog caveats, no new benchmark data. [expert-opinion] (novelty: 3)
- 2026-05-25 — Exposure to size-specific particulate matter accelerates DNA methylation aging in people with HIV.: Adds size-specific ambient particulate matter (PM10 strongest) as a short-term environmental exposure linked to multi-clock DNAm age acceleration in people with HIV — extends the exposure catalog from chronic general-population PM signals to short-term, size-resolved PM in a clinical subpopulation, observational. [human-observational] (novelty: 3)
- 2026-07-12 — Blood Biochemistry Age Clock - An interpretable estimate of biological age and predictor of all-cause-mortality derived from routinely ordered blood biomarkers.: Adds BBAC — an 11-marker interpretable routine-blood-biochemistry clock trained on ACM risk profiles and validated in UKB/NHANES for mortality and eight chronic-disease incidence — to the clinical-lab clock catalog, matching or beating PhenoAge on AIC and reinforcing that lean, interpretable composites can rival established phenotypic-age constructs; observational. [human-observational] (novelty: 3)
- 2026-07-16 — Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.: Adds clonal hematopoiesis (with DNMT3A vs TET2 driver stratification and clone-size gradients) to the exposure catalog for epigenetic clocks via a ~7,000-adult systematic review and meta-analysis showing CHIP carriers have elevated age acceleration on Horvath, Hannum, PhenoAge, and GrimAge — bridges hematologic somatic mosaicism and DNAm clock readouts, observational. [human-observational] (novelty: 3)
- 2026-10-01 — Neighborhood poverty duration, timing, and severity from adolescence to early midlife and biological aging.: Adds neighborhood poverty duration, timing (mid-adulthood weighted), and severity across adolescence-to-midlife as a structured life-course exposure axis linked to GrimAge2, PhenoAge, and DunedinPACE acceleration in a racially diverse 25-year US cohort — extends the social-determinants exposure catalog beyond cross-sectional neighborhood snapshots, observational. [human-observational] (novelty: 3)
- 2026-07-27 — Residential context and epigenetic age acceleration among older-age black and white Americans: Findings from the health and retirement study, 2010-2016.: Adds residential racial composition and neighborhood-level SES to the omic-biomarker exposure catalog via an HRS multigroup SEM across GrimAge, PhenoAge, and DunedinPoAm38, with race-stratified associations (present in White, largely absent in Black participants) — extends social-determinants exposure coverage with explicit heterogeneity by racial group, observational. [human-observational] (novelty: 3)
- 2026-08-05 — Substance use and epigenetic age acceleration: Associations with alcohol, tobacco, illicit drugs, and SUD severity.: Adds opioid use, clinically significant alcohol use, multiple nicotine-product forms, and validated SUD severity as exposure classes linked to GrimAge2 and DunedinPACE acceleration in a state-representative adult sample — extends the omic-biomarker exposure catalog from single-substance to multi-substance and severity-graded inputs, observational. [human-observational] (novelty: 3)
- 2026-08-22 — Ensemble DNA methylation clock demonstrates Immune-metabolic aging signatures associated with mortality.: Adds a stacked ensemble DNAm survival clock (190 CpGs, Framingham) to the omic-clock catalog that beat PhenoAge and matched GrimAge on all-cause mortality while surfacing immune-metabolic CpG signatures — incremental benchmark favoring ensemble over single-model clock architectures, observational. [human-observational] (novelty: 3)
- 2026-10-02 — Blood cell composition reveals distinct biological interpretation of DNA methylation age and age acceleration.: Adds a cell-composition deconvolution caveat to the omic-clock catalog: blood immune-cell proportions (notably naïve vs memory T cells) explain a majority of DNAmAge variance but little of AgeAccel’s outcome-linked signal — reinforces that composite blood clocks conflate immune-aging substructure with other aging processes and that organ/cell-resolved readouts matter. [human-observational] (novelty: 3)
- 2026-10-05 — Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.: Adds early-onset colorectal adenocarcinoma to the omic-biomarker outcome catalog via a ~200,000-adult Korean prospective cohort where PhenoAge acceleration tracked EOCRC adenocarcinoma but not neuroendocrine tumors — histology-specific signal supports organ/subtype-resolved use of clinical-lab aging clocks, observational. [human-observational] (novelty: 3)
- 2026-10-06 — Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.: UK Biobank integrated exposome+metabolome analysis (>45,000 participants): plasma metabolic signatures mediated a substantial share of the association between biological-age acceleration (PhenoAge, KDM-BA) / frailty and macular thinning, with adverse exposomes acting through aging and metabolic pathways — adds a retinal-structural outcome and an exposome→metabolome→aging-clock pathway to the omic-biomarker catalog, observational. [human-observational] (novelty: 3)
- 2026-10-06 — A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.: Same CKMAI NHANES study adds a domain-tailored (CKM-pathway) ML aging index to the clock catalog that beat PhenoAge, KDM, and CMI for mortality and high-risk CKM prediction — reinforces that disease-pathway-specific composite scores can outperform general-purpose biological-age clocks in their target domain, observational. [human-observational] (novelty: 3)
- 2026-10-05 — AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.: Scoping review of AI-based IC measurement centers on digital rather than omic biomarkers, implicitly contrasting the digital-biomarker layer with molecular omic clocks as parallel aging-measurement surfaces — tangential to this page, no new omic data. [expert-opinion] (novelty: 3)
- 2026-10-06 — Intrinsic capacity modifies the risk of depression and anxiety through metabolomic signature.: UK Biobank prospective study adds incident depression and anxiety to the omic-biomarker outcome catalog via a 59-metabolite mediator of IC-deficit→mood-disorder risk with PRS interaction — extends outcome coverage beyond physical/cognitive aging, observational. [human-observational] (novelty: 3)
- 2025-12-15 — Discrimination of normal from slow-aging mice by plasma metabolomic and proteomic features.: Preclinical ML classifier trained on mouse plasma metabolomics+proteomics generalized across held-out geroprotective interventions, sexes, and long-lived mutants — extends the omic-biomarker catalog with a candidate drug-screening readout at the mouse stage, with the usual caveat that classifier movement is not evidence of extended lifespan in any individual. [animal-model] (novelty: 3)
- 2026-10-01 — Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.: Adds a 3D chromatin imaging modality (ChromAgeNet, AUROC 0.77 on murine HSCs) to the aging-biomarker catalog as an image-based alternative to sequencing-derived clocks — preclinical and tissue-restricted, extends the measurement surface rather than validating any existing omic clock. [animal-model] (novelty: 3)
- 2026-07-06 — From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.: Framework review positions organ-level multi-omic age gaps as a precision-geromedicine substrate while flagging that tissue-of-origin for circulating omic signals is usually unproven — a caveat layer on top of the existing organ-clock catalog, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-07 — AI-driven advances in vascular aging research: From mechanisms to precision medicine.: Field-level review argues AI applied to large-scale multi-omics can accelerate discovery of novel aging biomarkers and support precision vascular-aging stratification — synthesis of an already-active trend, no new primary omic validation. [expert-opinion] (novelty: 3)
- 2026-04-24 — Mitochondrial Dysfunction and Telomeric Shortening as Long-term Complications After COVID-19.: Prospective post-hospitalization COVID cohort (1–2 year follow-up) adds SARS-CoV-2 to the exposure catalog, tying sustained leukocyte telomere shortening and mitochondrial protein alterations to pulmonary fibrotic sequelae — links long-COVID to canonical aging hallmarks (telomere attrition, mitochondrial dysfunction) as observational biomarker correlates, not causal mediators. [human-observational] (novelty: 3)
- 2026-07-14 — A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.: Review consolidates circulating SASP/senescence proteins (GDF15, Activin A among the most reproducible) as a human-focused biomarker layer that cuts across neuro, pulmonary, cardiometabolic, and musculoskeletal domains and is modulated by emerging senotherapeutics — positions the SASP panel as a candidate overlay on existing omic clocks, synthesis only. [expert-opinion] (novelty: 3)
- 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: Brain aging clocks review consolidates methodological advances from global metrics to multi-modal cellular-resolution brain clocks and ties them to senescence and related hallmarks — extends the omic-clock catalog with a tissue-specific (brain) synthesis layer, no new benchmark data. [expert-opinion] (novelty: 3)
- 2026-06-19 — Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.: Conceptual review proposes ‘epigenetic transition windows’ as a unifying regulatory architecture for immune-state plasticity across the lifespan, reframing inflammaging, trained immunity, resolution failure, and tumor escape as failures of regulated state transition rather than excess signaling — framework synthesis, no new primary data, and relevant to immune-aging omic readouts (IMMAX, SASP scores, proteomic inflammaging) as a reminder that scalar immune-age metrics may miss transition-window dynamics. [expert-opinion] (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: Review frames blood as both a biomarker compartment and a therapeutic interface via the ‘circulating senosome,’ arguing that multi-omic plasma readouts (proteomic, metabolomic, cfDNA, microbial, SASP) should be integrated rather than scored in isolation — conceptual synthesis extending the omic-biomarker catalog without new benchmark data. [expert-opinion] (novelty: 3)
- 2026-08-18 — Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.: Multi-omics observational study ties intrinsic capacity decline to 57 gut bacterial species and 56 serum metabolites (amino acids, carnitines, bile acids, senescence-related metabolites) after rigorous multivariable adjustment — adds IC to the omic-biomarker outcome catalog with a jointly microbial+metabolomic signature, cross-sectional. [human-observational] (novelty: 3)
- 2026-07-15 — Chronic kidney disease-stratified plasma proteomic signatures of probable sarcopenia: A UK biobank cohort study.: Adds CKD as a stratification axis for a probable-sarcopenia proteomic signature in UK Biobank (n≈52k): probable sarcopenia >2× more common in CKD and associated with a broad COL6A3/GDF15-led proteomic pattern linking ECM, inflammation, renal, and lipid-metabolic layers — extends the omic-biomarker catalog with a comorbidity-stratified muscle/kidney signature, observational only. [human-observational] (novelty: 3)
- 2026-10-01 — Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.: LBC1936 head-to-head benchmark: proteomic liver, immune, and heart aging clocks each predicted 16-year all-cause mortality but were outperformed by GrimAge2, brain-volume MRI, lung function, and cognition — rare comparative evidence placing organ-specific proteomic clocks below both a top-tier methylation clock and several non-omic physiologic measures in a single cohort. [human-observational] (novelty: 3)
- 2025-11-18 — Glycemic status-dependent proteomic signatures of biological aging for health risk prediction.: Adds glycemic status as a stratification axis for the omic-clock catalog: UK Biobank-derived glycemic-specific proteomic aging scores (ProAS) outperform conventional risk factors for mortality and incident disease prediction in normoglycemic, prediabetic, and diabetic subgroups, with GDF15/EDA2R/WFDC2 as cross-stratum anchors — stratified-clock evidence that a single pooled proteomic clock may underweight metabolic-context effects, observational. [human-observational] (novelty: 3)
- 2026-10-01 — A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.: Deep-learning composite SASP Score built from blood proteomics is reported as an independent predictor of mortality and incident chronic diseases and moved under 18 months of multimodal exercise in an external RCT — extends the omic-clock catalog with a senescence-burden-anchored proteomic score that is both outcome-associated and intervention-responsive, but responsiveness ≠ demonstrated de-aging. [human-observational] (novelty: 4)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: Translational review maps TCM formulas onto hallmarks of aging (mitochondrial homeostasis, cellular senescence, stem-cell maintenance, gut microbiota) and argues omic aging clocks plus AI/network-pharmacology are needed to evaluate multi-component interventions — extends the omic-biomarker catalog with a TCM use-case framing, no new benchmark or intervention responsiveness data. [expert-opinion] (novelty: 3)
- 2026-09-24 — Organ‐Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox: Adds alcohol intake to the omic-biomarker exposure catalog: organ-specific proteomic aging clocks show organ-dependent, non-uniform associations with drinking behavior, arguing the classic J-shaped ‘healthy drinker’ pattern breaks down when aging is measured per-organ rather than as a composite — observational, no intervention data. [human-observational] (novelty: 3)
- 2026-09-22 — Acute viral respiratory infections are not associated with an increased IMMune Age indeX (IMMAX) four weeks after infection: a prospective observational cohort study.: Prospective cohort testing IMMAX (flow-cytometry immune-age surrogate) after mild-to-moderate community-acquired viral respiratory infection found no four-week post-recovery elevation, with a distinct transient acute SARS-CoV-2 immune-cell shift — extends the omic-clock catalog with a meaningful negative finding on infection-driven clock movement and reinforces that acute-phase perturbations need not translate into sustained clock acceleration. [human-observational] (novelty: 3)
- 2026-07-08 — Long-term exposure to air pollution, proteomic aging clocks, and liver-related outcomes in Chinese adults.: Adds ambient air pollution (single and multi-pollutant mixtures) to the omic-biomarker exposure catalog: China Kadoorie Biobank cohort found higher long-term pollutant exposure associated with liver-related events and mortality, with ProtAge proteomic clock partially mediating the effect — extends outcome coverage to hepatology but partial mediation is not proof that lowering ProtAge blocks pollutant-driven liver disease. [human-observational] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: Adds heart failure to the omic-biomarker outcome catalog: longitudinal organ-specific proteomic age gaps (kidney, lung, immune) predicted adverse events beyond NT-proBNP and troponin T and accelerated prior to events — first longitudinal (vs cross-sectional) demonstration that organ-resolved proteomic clocks carry prognostic signal on top of standard cardiac biomarkers, observational. [human-observational] (novelty: 4)
- 2026-09-18 — Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes.: Adds plasma metals (copper, selenium, antimony) as an environmental-exposure class linked to multiple biological-age acceleration readouts in Chinese adults, with inflammation and oxidative stress as partial mediators and diabetes as an effect modifier — extends the omic-biomarker exposure catalog, cross-sectional and no intervention data. [human-observational] (novelty: 3)
- 2026-09-26 — Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood.: Adds midlife cognition (peak performance, retest gains, intra-individual processing-speed variability, between-burst forgetting) to the omic-biomarker outcome catalog: multiple epigenetic clocks plus DunedinPACE tracked cognitive features while chronological age uniquely tracked forgetting (n=139 measurement-burst study) — extends outcome coverage without demonstrating that clock movement drives cognitive change. [human-observational] (novelty: 3)
- 2026-09-15 — Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.: Small RCT-derived plasma proteomics (n=34, 12 weeks) links a 33-protein aerobic-exercise-specific immune/vascular signature to episodic memory gains and a 24-protein inflammatory signature shared with gross-motor training — an intervention-responsive proteomic readout in the omic-biomarker catalog, though proteomic movement here is not evidence of clock-level de-aging. [human-rct] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: Large-scale construction of 38 sex-specific aging clocks across 15 organ systems and multiple omics layers found marked female–male divergence in genetic liability, organ-resolved proteomic networks, mortality/disease prediction, and preclinical Alzheimer’s cognitive trajectories — a structural argument that sex-pooled clocks in the omic-biomarker catalog can obscure organ- and sex-specific aging signal; observational. [human-observational] (novelty: 4)
- 2026-09-22 — Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.: Adds a tissue-resolved transcriptomic clock + drug-score resource (49 GTEx human tissue/cell categories × LINCS compounds) to the omic-clock catalog, showing that most compounds move age-score direction differently across tissues — reinforces that composite or single-tissue clock readouts can hide opposite tissue-level effects (rapamycin scored net pro-aging transcriptionally here despite geroprotective claims elsewhere). Observational/computational resource, no outcome data. [human-observational] (novelty: 3)
- 2026-09-01 — An open benchmark and language models for AI in aging biology.: LongevityBench (open multi-domain AI benchmark for aging biology) reports omics age prediction as the hardest task for frontier LLMs, with compact fine-tuned Longevity-LLMs (0.6B–9B) matching or exceeding larger general models — a tooling/evaluation contribution highlighting how brittle current AI is on omic-clock inference, not new omic biomarker validation. [expert-opinion] (novelty: 4)
- 2026-09-15 — Multiparametricmapping reveals tissue-specific mitochondrial aging trajectories.: Preclinical multiparametric live-imaging study (2p-FLIM + MitoSLIT) maps mitochondrial aging as tissue- and compartment-specific (soma vs axon) spatiotemporal trajectories rather than a uniform bioenergetic decline — adds a spatially resolved functional-imaging layer to the omic-biomarker catalog and cautions against collapsing mitochondrial aging into a single scalar readout. [animal-model] (novelty: 3)
- 2026-09-20 — CSenescence-associated-secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data.: Adds early psychosis to the omic-biomarker catalog of conditions carrying an accelerated-aging plasma proteomic signature (SASP index + TNF/monocyte-chemotaxis pathway enrichment), with cross-sectional links to BMI and psychological well-being — extends exposure/phenotype coverage, no intervention or longitudinal data. [human-observational] (novelty: 3)
- 2026-09-16 — Aging as Loss of Biological Self-Correction: A Geroscience Framework for Longevity, Inflammaging, and Restored Resilience.: Geroscience review reframes aging as progressive loss of biological self-correction and argues static omic clocks and hallmark panels should be complemented by dynamic stress-response recovery metrics to capture correction fidelity — positions omic biomarkers as necessary-but-insufficient inputs, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: NHP (rhesus macaque) paired plasma/CSF proteomic mapping adds a compartment-resolved, human-benchmarked reference layer to the omic-biomarker catalog for senescence and neuropathology markers — preclinical translational scaffolding, not new human outcome evidence. [animal-model] (novelty: 3)
- 2026-09-18 — System-Specific Epigenetic Aging Signatures in Autistic Adults.: Adds autism to the exposure catalog interrogated with SystemsAge organ-system DNAm clocks: brain/blood/liver system-specific epigenetic age elevated in autistic adults while global DNAm age unchanged, with signal loading on psychosocial circumstances rather than clinical severity — extends omic-biomarker coverage into neurodevelopmental populations and reinforces that organ-resolved clocks can dissociate from composite readouts. Observational, no intervention data. [human-observational] (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: Serum bile-acid metabolomics case-control adds 3β-HDCA, GLCA, and sleep-interacting TLCA as sarcopenia-associated candidates on the emerging gut–bile-acid–muscle axis — extends the omic-biomarker catalog into bile-acid metabolites with a functional (gait speed) readout, observational only. [human-observational] (novelty: 3)
- 2026-09-09 — Childhood trauma, accelerated biological aging and chronic pain across two population cohorts: Adds early-life psychosocial adversity (childhood trauma) to the omic-biomarker catalog of upstream exposures linked to second- and third-generation epigenetic clock acceleration and a downstream chronic-pain outcome, with sex-stratified mediation — extends exposure coverage, observational only. [human-observational] (novelty: 3)
- 2026-09-07 — Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment: News-report of a phase 2a trial integrating proteomic aging clocks for concurrent geroprotective assessment — extends the omic-biomarker catalog into trial-embedded intervention responsiveness use, but clock movement in such a design would still not equal proof of de-aging. [expert-opinion] (novelty: 3)
- 2026-09-11 — Scientists find signs of extreme aging and youth in the same 117-year-old: News report of a single 117-year-old supercentenarian case in which multi-omic profiling reportedly showed concurrent signatures of extreme aging and retained youthful features — extends the omic-biomarker catalog with a within-individual divergence signal at extreme longevity, but n=1 press coverage, not a benchmark. [human-observational] (novelty: 3)
- 2026-09-09 — The redox architecture of gestational diabetes mellitus: from cellular stress engine to epigenetic and mitochondrial rewiring.: Adds gestational diabetes to the catalog of exposures linked (in review form) to multi-omic aging readouts, spanning epigenetic, mitochondrial, and metabolic layers with a claimed persistent metabolic-memory signal in both mother and offspring — expert synthesis, no benchmark or intervention responsiveness data. [expert-opinion] (novelty: 3)
- 2026-09-12 — Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.: Adds a Proteomic Inflammaging Score (PIS) to the omic-clock catalog as an inflammation-anchored plasma-protein score that beat conventional inflammatory and aging markers for mortality and multimorbidity prediction in UK Biobank — observational benchmark, not evidence that lowering PIS slows aging. [human-observational] (novelty: 3)
- 2026-08-10 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers: Registered 12-week placebo-controlled trial of Urolithin A, fisetin, and their combination will read out multi-modal aging biomarkers (methylation, inflammation, microbiome) plus sleep quality in middle-aged/older adults — extends the omic-biomarker catalog into mitophagy + senolytic-flavonoid intervention responsiveness, but trial announcement only, no data yet. [expert-opinion] (novelty: 3)
- 2026-08-18 — A Novel Approach Utilizing Organ Specific Age Proteomics: Adds an oncology risk-stratification use case to the omic-biomarker catalog: pairing organ-specific proteomic clocks with p16INK4A T-cell senescence to test whether immune aging tracks multi-organ aging and predicts chemo late toxicities — use-case framing, not new validation data. [expert-opinion] (novelty: 3)
- 2026-08-28 — Michael Snyder: We Need to Track Health, Not Disease: Media restatement of Snyder’s continuous multi-omic monitoring thesis (proteomics, metabolomics, transcriptomics layered onto wearable streams as a proactive health readout) — expert positioning only, no new primary evidence. [expert-opinion] (novelty: 3)
- 2026-09-09 — Comparing the Responsiveness of Epigenetic Aging Biomarkers: News-report of a study comparing responsiveness of several DNAm aging biomarkers across longevity interventions — adds an intervention-responsiveness comparison layer to the omic-clock catalog, secondhand coverage only. [expert-opinion] (novelty: 3)
- 2025-12-22 — Associations between persistent organic pollutants exposure and DNA methylation aging biomarkers: insights from a nationally representative study.: NHANES analysis pairing serum POPs with twelve epigenetic clocks adds compound-class-specific, sex- and age-stratified environmental exposure signals to the omic-biomarker catalog — observational, and bidirectional PCB-vs-furan/OCP directions caution against treating any single clock’s response as a unified ‘aging’ readout. [human-observational] (novelty: 3)
- 2026-07-20 — Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women: Planned trial of semaglutide and tirzepatide in postmenopausal women with obesity will use aging biomarkers, physical function, and vascular function as endpoints — extends the omic-biomarker catalog into GLP-1/GIP intervention responsiveness, but trial announcement only, no data yet. [expert-opinion] (novelty: 3)
- 2026-09-08 — 100-Year Human Aging Study: Announcement of the 100-Year Human Aging Study — a prospective lifespan cohort planning to test whether multi-omic aging readouts predict mortality, incident disease, and disability; protocol/infrastructure announcement, no data yet. [expert-opinion] (novelty: 4)
- 2026-07-08 — Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong: Study proposal for integrated multi-omics (genetic, proteomic, metabolomic, microbiota) profiling of Hong Kong Chinese long-lived individuals — extends the geographic scope of centenarian omics beyond mostly-European cohorts, but no results reported yet. [expert-opinion] (novelty: 3)
- 2026-08-27 — Associations Between Accelerometer‐Assessed Sleep Patterns, Proteomic Signatures, and Hallmarks of Aging in Adulthood: Adds objective sleep behavior as an upstream exposure correlated with proteomic aging readouts and hallmark-of-aging markers, extending the omic-biomarker catalog into wearable-derived lifestyle inputs — association only. [human-observational] [human-observational] (novelty: 3)
- 2026-09-04 — Tissue‐Level Transcriptomic Entropy Reveals Organ‐Specific Aging Patterns and Predicts Cancer Progression: Observational transcriptomic study introduces tissue-level expression entropy as an organ-specific aging metric that also associates with cancer progression — expands the omic-clock catalog with an information-theoretic (non-regression) readout, without intervention data. [human-observational] (novelty: 3)
- 2026-03-25 — Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson’s Progression Markers Initiative cohort.: PPMI observational cohort links multi-generational epigenetic clock acceleration to tremor-dominant motor progression in Parkinson’s disease with male-predominant effect — adds a disease- and phenotype-specific outcome to the omic-clock catalog without demonstrating causality. [human-observational] (novelty: 3)
- 2026-06-10 — Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact.: Field-level review argues AI can traverse the geroscience continuum (hallmark biology → omic biomarker discovery → geroprotector design → clinic) only with hierarchical experimental validation and anti-digital-ageism safeguards to prevent spurious correlations — synthesis of an emerging trend, no primary data. [expert-opinion] (novelty: 3)
- 2026-06-22 — Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.: Population-based NMR metabolomics case-control extends the omic-biomarker catalog with subtype-specific stroke-associated metabolic signatures and a partial-mediation age–stroke metabolic risk score — incremental human observational evidence for outcome-linked metabolomic panels. [human-observational] (novelty: 3)
- 2026-06-26 — Meta-analysis of DNA methylation aging signatures in 17 human tissues.: Cross-tissue methylation meta-analysis (>15,000 profiles, 17 tissues) surfaces both conserved and tissue-specific epigenetic aging signatures plus an NAD-metabolism-linked modifiable cluster and PCDHGA1 hub — strengthens the multi-tissue reference layer for omic-clock construction without providing intervention or outcome data. [human-observational] (novelty: 3)
- 2026-07-02 — DNA methylation clock in bull sperm cells reveals the epigenetic aging characteristics and impact on fertility.: Bull sperm DNA methylation clock adds a germline-tissue, cross-species (human–bull) epigenetic readout to the omic-clock catalog, with association to semen quality and fertility traits in Holstein bulls — expands the tissue coverage of methylation clocks beyond somatic panels. [animal-model] (novelty: 3)
- 2026-07-24 — Decoding aging clocks from a metabolomic perspective.: Review of metabolomic aging clocks proposes a structured construction workflow plus three-phase causal validation to raise biological plausibility across omic clocks — a methodological framework contribution, not an empirical benchmark. [expert-opinion] (novelty: 3)
- 2026-08-04 — Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.: Cross-sectional community-dwelling older-adult cohort found NfL, CXCL9, IL-6, and TNFRSF11B independently associated with WHO intrinsic capacity, with NfL partially mediating CXCL9 and TNFRSF11B effects — extends the multi-omic candidate panel for functional aging but not a longitudinal or interventional readout. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Circulating C-Terminal Agrin Fragment is Associated with Impaired Physical Performance in Aging and Chronic Disease: A Systematic Review and Meta-Analysis.
15-nov-2026
novelty 3
per-area 3
strengthens
Artificial intelligence-assisted discovery of natural product geroprotectors: target prediction, aging biomarker identification, and drug repurposing.
13-nov-2026
novelty 2
per-area 2
mentions
Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.
11-nov-2026
novelty 3
per-area 3
strengthens
500 people, six months, one goal: Reverse aging
10-nov-2026
novelty 2
per-area 2
mentions
Routine Blood Tests Form Core of Biological Age Models, Systematic Review Finds
10-nov-2026
novelty 2
per-area 2
mentions
Age: a modifiable risk factor for cardiovascular disease?
02-nov-2026
novelty 2
per-area 2
strengthens
Immunophenotypic Profiles of General Chinese Population during Natural Aging.
01-nov-2026
novelty 3
per-area 3
strengthens
Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging.
30-oct-2026
novelty 2
per-area 2
strengthens
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship.
26-oct-2026
novelty 2
per-area 2
mentions
Dissecting the shared genetic architecture of adipose tissue aging and aging-related lipid-metabolic dysfunction: a multivariate genomic analysis.
26-oct-2026
novelty 3
per-area 3
strengthens
Brain care score and retinal health: structural and metabolic insights from the UK Biobank.
09-oct-2026
novelty 3
per-area 3
strengthens
Chronic inflammation and multiple dimensions of aging among women in the Philippines.
07-oct-2026
novelty 3
per-area 3
strengthens
Do Children Who Develop Faster Go on to Age Faster in Midlife?
07-oct-2026
novelty 4
per-area 2
mentions
Dietary preference, biological aging, and incident dementia: a prospective cohort study.
07-oct-2026
novelty 3
per-area 2
mentions
Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.
07-oct-2026
novelty 3
per-area 3
strengthens
Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.
06-oct-2026
novelty 3
per-area 3
strengthens
A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.
06-oct-2026
novelty 3
per-area 3
strengthens
Circulating TNF-α, CCL2 and IL-6 are associated with blood-based epigenetic age and targeted CpG methylation signatures in aging mice.
06-oct-2026
novelty 2
per-area 2
strengthens
Intrinsic capacity modifies the risk of depression and anxiety through metabolomic signature.
06-oct-2026
novelty 3
per-area 3
strengthens
Metabolic and Functional Consequences of Aging in Health and Disease
05-oct-2026
novelty 2
per-area 2
mentions
The Biomarkers That Predict Mortality Risk
05-oct-2026
novelty 2
per-area 2
mentions
An Aging Clock Based on Images of Hematopoietic Stem Cell Nuclei
05-oct-2026
novelty 3
per-area 3
strengthens
Fat Infiltration into Muscle Tissue as a Biomarker of Aging
05-oct-2026
novelty 2
per-area 1
mentions
Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.
05-oct-2026
novelty 3
per-area 3
strengthens
AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.
05-oct-2026
novelty 3
per-area 3
strengthens
Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain.
05-oct-2026
novelty 2
per-area 2
mentions
Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies.
03-oct-2026
novelty 2
per-area 2
mentions
The Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work Ability
02-oct-2026
novelty 2
per-area 2
mentions
Accelerated Epigenetic Aging Correlates with Later Loss of Memory Function
02-oct-2026
novelty 2
per-area 2
mentions
Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality
02-oct-2026
novelty 3
per-area 3
strengthens
Blood cell composition reveals distinct biological interpretation of DNA methylation age and age acceleration.
02-oct-2026
novelty 3
per-area 3
strengthens
Proteomic and bioinformatic profiling of the aging mouse heart-diaphragm system.
02-oct-2026
novelty 2
per-area 2
mentions
Global Leaders in Geroscience Convene for Biomarkers of Aging
01-oct-2026
novelty 2
per-area 2
mentions
Organ-Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox.
01-oct-2026
novelty 3
per-area 3
strengthens
Neighborhood poverty duration, timing, and severity from adolescence to early midlife and biological aging.
01-oct-2026
novelty 3
per-area 3
strengthens
Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.
01-oct-2026
novelty 3
per-area 3
strengthens
Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.
01-oct-2026
novelty 3
per-area 3
strengthens
A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.
01-oct-2026
novelty 4
per-area 4
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Associations between socioeconomic position index and epigenetic aging in NHANES.
30-sep-2026
novelty 2
per-area 2
mentions
Advancing aging biomarkers and intervention discovery at the TimePie Longevity Forum.
30-sep-2026
novelty 2
per-area 2
mentions
Westlake Longevity Cohort
29-sep-2026
novelty 3
per-area 3
strengthens
Accelerated biological aging in the association between early-life tobacco smoke exposure and dementia risk: An exploratory mediation analysis.
29-sep-2026
novelty 2
per-area 2
strengthens
Epigenetic age acceleration is associated with brain connectivity changes and the risk of major depression after trauma
28-sep-2026
novelty 3
per-area 3
strengthens
Uncertainty redefines biological age
28-sep-2026
novelty 4
per-area 4
strengthens
A New Metric for Overall Senescent Cell Burden
28-sep-2026
novelty 3
per-area 3
strengthens
Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images
28-sep-2026
novelty 3
per-area 3
strengthens
Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood.
26-sep-2026
novelty 3
per-area 3
strengthens
Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.
26-sep-2026
novelty 3
per-area 3
strengthens
Biological aging for the advancement of biogerontology: Between hopes and hypes.
26-sep-2026
novelty 2
per-area 2
mentions